<DOC>
	<DOC>NCT02422602</DOC>
	<brief_summary>This study is multicentric, single-blind, and interventionnal with a randomization into two parallel arm, between a standard of care information and an additionnal information of the patient, with a 12 month follow up. The aim of this study is to evaluate the effectiveness of a personalized information programm versus information provided from standard of care in patients taking Xarelto for Stroke Prevention in Atrial Fibrillation.</brief_summary>
	<brief_title>Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>All patients treated with rivaroxaban chronically, (atrial fibrillation nonvalvular under current AMM) for less than one year whatever anti vitamin K treatment history Affiliate or beneficiary of a social security system. Patient who formulated its "does not oppose" to participate in this research Age higher than or equal to 18 years Opposition to participation Patient don't understand french language Patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers) Tutorship or curatoship Lawprotected patient Pregnant women or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Patients</keyword>
	<keyword>treated by Rivaroxaban</keyword>
</DOC>